BioStem Technologies, Inc. to Attend 2020 Perinatal Stem Cell Society Conference
February 27, 2020 12:08 ET
|
BioStem Technologies, Inc.
Pompano Beach, Feb. 27, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue-based...
BIOSTEM TECHNOLOGIES, INC. ANNOUNCES CORPORATE UPDATE; RESIGNATION OF CHAIRMAN AND CEO, APPOINTMENT OF INTERIM CEO AND CHARIMAN; BOARD INITIATES EXECUTIVE SEARCH FOR PERMANENT CEO
October 29, 2019 17:57 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FL, Oct. 29, 2019 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC/PK:BSEM) today announced Henry Van Vurst would be stepping down as the company's Chief Executive Officer and as...
BioStem Technologies, Inc. Announces Corporate Update
March 25, 2019 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, March 25, 2019 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), today provided a corporate update to the Company’s continuing growth...
BioStem Technologies Releases Third Quarter 2018 Shareholder Update
December 10, 2018 11:48 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Dec. 10, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem Technologies” or the “Company”), a global life sciences corporation providing innovative...
BioStem Technologies Selects PCG Advisory Group for Investor Relations and Strategic Communications
October 17, 2018 08:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Oct. 17, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation providing innovative technologies...
BioStem Life Sciences, Inc., Subsidiary of BioStem Technologies, Inc., Announces Entry into Market with Four Amniotic Products
October 01, 2018 10:45 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Oct. 01, 2018 (GLOBE NEWSWIRE) -- BioStem Life Sciences (“Life Sciences” or the “Company”), a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM), a...
BioStem Technologies Inc. to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House
September 19, 2018 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Sept. 19, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies...
Nesvik Pharmaceuticals, Inc., a Subsidiary of BioStem Technologies, Inc., Announces Engagement of The Gnomon Group for Pre-Investigational New Drug Application Strategy
September 17, 2018 10:43 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals, Inc., a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), focused on...
Nesvik Pharmaceuticals, Inc., Receives Updated U.S. FDA Establishment Registration in Light of New Product Development
August 28, 2018 10:10 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals, Inc., a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), focused on...
BioStem Technologies, Inc. Completes 2016, 2017 Audit of Financial Statements
August 17, 2018 09:30 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL., Aug. 17, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM), a global life sciences corporation, providing innovative technologies with a concentration in...